Cargando…
Neutralizing hepatitis B
Despite an effective vaccine, hepatitis B virus (HBV) remains a major public health threat since chronic infection leads to liver disease and cancer. Hehle et al. (https://doi.org/10.1084/jem.20200840) discovered human-derived antibodies that potently neutralize the virus. Will this help a cure?
Autor principal: | Robbiani, Davide F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537398/ https://www.ncbi.nlm.nih.gov/pubmed/32790869 http://dx.doi.org/10.1084/jem.20201261 |
Ejemplares similares
-
A dark side to NS1 antibodies?
por: Robbiani, Davide F., et al.
Publicado: (2021) -
Thinking from event of Kangtai hepatitis B vaccination
por: Ruan, Li
Publicado: (2014) -
The BAFFling persistence of memory B cells
por: Brooks, Jeremy F., et al.
Publicado: (2020) -
T2B or not to B: Calming neutrophils offshore
por: Munir, Hafsa, et al.
Publicado: (2021) -
Cbls boost B cells
por: Linterman, Michelle A.
Publicado: (2020)